Isabel Alicia Lüthy

4PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 28, 2024
FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression.

María S Rodriguez, Yamil D Mahmoud, Silvia Vanzulli

|Sep 19, 2023
The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models.

Martina Jabloñski, María Sol Rodríguez, Ezequiel Mariano Rivero

|Apr 26, 2020
Agonist Effects of Propranolol on Non-Tumor Human Breast Cells.

Lucía Gargiulo, Ezequiel Mariano Rivero, Nicolás di Siervi

|Jun 21, 2019
Prognostic significance of α- and β2-adrenoceptor gene expression in breast cancer patients.

Ezequiel Mariano Rivero, Leandro Marcelo Martinez, Carlos David Bruque

Pageof 1